Meshkat S

Efficacy and Safety of Psychedelic Microdosing on Psychological Outcomes in Healthy Adults: A Systematic Review and Meta-analysis.

Meshkat S, Leung M, Meshkat S +13

Therapeutic Potential of Psilocybin in Psychiatric Disorders: Mechanisms, Efficacy, and Clinical Implications.

Meshkat S, Jha MK, Bhat V

ArticlePsychedelics

Magnitude of response in treatment and control groups within psychedelic trials for psychiatric disorders: A meta-analysis.

Meshkat S, Lin Q, Sousa-Ho R +15

Examining the effects of psilocybin-assisted psychotherapy on anhedonia in treatment-resistant depression.

Kaczmarek ES, Rodrigues NB, Chisamore N +8

ArticlePsychedelics

Toward a definition of treatment-resistant posttraumatic stress disorder: A systematic review.

Al-Shamali HF, Meshkat S, Janssen-Aguilar R +12

Cognitive outcomes following psilocybin-assisted therapy in treatment-resistant depression: A post-hoc analysis of a randomized, waitlist-controlled trial.

Johnson DE, Meshkat S, Kaczmarek ES +11

ArticleMDMA

Interventional Psychiatry and Emerging Treatments for Posttraumatic Stress Disorder (PTSD): A Systematic Review.

Janssen-Aguilar R, Meshkat S, Al-Shamali HF +14

Examining mystical experiences as a predictor of psilocybin-assisted psychotherapy for treatment-resistant depression.

Brudner RM, Kaczmarek E, Blainey MG +9

Therapeutic Effects of Low-Dose Psilocybin in Depression and Other Mental Disorders: A Systematic Review.

Meshkat S, Fang H, Sousa-Ho R +11

Efficacy and safety of psilocybin for the treatment of substance use disorders: A systematic review.

Meshkat S, Malik G, Zeifman RJ +12

Pharmacokinetics of Psilocybin: A Systematic Review.

Meshkat S, Al-Shamali H, Perivolaris A +13

Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study Participation: Comparaison des effets antidépresseurs de la psychothérapie assistée par la psilocybine (PAP) chez les personnes non médicamentées à la sélection initiale et les personnes ayant arrêté les médicaments pour participer à l'étude.

Chisamore N, Kaczmarek ES, Doyle Z +8

Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression in Bipolar II Disorder.

Meshkat S, Kaczmarek E, Doyle Z +7

Psychedelics and Suicide-Related Outcomes: A Systematic Review.

Meshkat S, Malik T, Zeifman R +13

Psilocybin-assisted massed cognitive processing therapy for chronic posttraumatic stress disorder: Protocol for an open-label pilot feasibility trial.

Meshkat S, J Zeifman R, Stewart K +5

Impact of psilocybin on cognitive function: A systematic review.

Meshkat S, Tello-Gerez TJ, Gholaminezhad F +11

Europe PMC2024

A comparison between psilocybin and esketamine in treatment-resistant depression using number needed to treat (NNT): A systematic review.

Wong S, Kwan ATH, Teopiz KM +8

Europe PMC2024